Optimi Health Announces Closing of Non-Brokered Private Placement and Debt Settlement @Optimi_Health #MDMA #psilocybin #psychedelics #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Financing #PrivatePlacement #CSEStocks #SmallCaps #Investing

Vancouver, British Columbia--(Newsfile Corp. - January 28, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psychedelics pharmaceutical manufacturer specializing in botanical psilocybin and MDMA, announces it has closed the second and final tranche (the "Second Tranche") of its non-brokered private placement (the "Offering") of units of the Company (each, a "Unit") at a price of $0.30 per Unit. Under the Second...


http://dlvr.it/THf1Jw

Comments

Popular posts from this blog

SEC Investor Advisory Committee to Discuss Exempt Offerings and Accredited Investors at September 21 Meeting #Banking #FinancialServices

Cleantek Industries Inc. Announces a Twelve-Month Extension of Credit Facility #CTEK.CA #CTEK.V #GLKFF #Investing #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Technology

Hearts Connect along the Silk Road, International Voluntary Service Seminar Held in Nanjing #